Abstract:OBJECTIVE To establish a serum-free culture system of dendritic cells (DCs) from chronic myeloid leukemia (CML) cells so that DCs vaccine may be applied to the adoptive immunotherapy of CML in the near future. METHODS Fetal calf serum, serum-free medium and autologous serum were used for culture of DCs. The usage of cytokines was classified into two groups: group A (stem cell factor, granulocyte/macrophage colony-stimulating-factor, tumor necrosis factor-alpha and interleukin-4) and group B (granulocyte/macrophage colony-stimulating-factor, tumor necrosis factor-alpha and interleukin-4). The phenotypes of DCs were analyzed by using indirect immunofluorescence and flow cytometry. Mixed leukocyte responses were performed by methyl thiazolyl tetrazolium (MTT) assay. Chromosome analysis of DCs can be achieved by displaying G banding. T cells from CML patients were stimulated with autologous DCs and T-cell cytotoxicity was measured by (MTT) assay. RESULTS CD34(+) cells or mononuclear cells were obtained from peripheral blood or bone marrow samples of eight patients of chronic-phase CML. Group A of serum-free medium was better than group B in expansion of total cell numbers and the rate of DCs. These results of serum-free medium were not significantly different from those of fetal calf serum medium, but the results of autologous serum medium were inferior to two groups above. The expression of major histocompatibility complex class II antigen on the surface of DCs was notable (> 50%), but the expression of CD83 and the costimulatory molecules CD86 was not noticeable (10% - 50%). Although CD1a(+)/CD14(-) DCs were potent stimulators of allogeneic lymphocytes, expansion of T cells from normal volunteers were not significant (average 27.2 fold at DCs: T cells ratio of 1:10). At day 12, CD1a(+) cells from three patients were studied by displaying G banding and Ph(+) cells in these populations were 100%, 98% and 60%, respectively. At an effector: target ratio of 40:1, 32% to 45% cytotoxicity was noted with DC-stimulated T cells against autologous leukemia cells. CONCLUSIONS A stable serum-free culture system of CML-DCs was established. The expression of CD83 and CD86 on the surface of CML-DCs and DCs' potent stimulation of allogeneic lymphocytes were not notable. DCs in CML patients can be derived from the malignant clone and these malignant DCs could induce anti-leukemic reactivity in autologous T lymphocytes without the necessity for additional exogenous antigens.

Development of a serum-free induction medium for the induction of human CD40+CD209+ dendritic cells from CD14+ monocytes

Induction of dendritic cells with IFN-alpha and GM-CSF from bone marrow mononuclear cells from patients with chronic myeloid leukemia

Large-scale production and directed induction of functional dendritic cells ex vivo from serum-free expanded human hematopoietic stem cells

Simplified Method to Generate Large Quantities of Dendritic Cells Suitable for Clinical Applications

Phenotypic and functional characteristics of dendritic cells derived from human peripheral blood monocytes

The synergistic and enhancive effects of IL-6 and M-CSF to expand and differentiate functional dendritic cells from human monocytes under serum-free condition

A two-step culture process for generating abundant CD14+ monocytes from human hematopoietic stem cells

Distinct Effect of CD40 and TNF-Signaling on the Chemokine/Chemokine Receptor Expression and Function of the Human Monocyte-Derived Dendritic Cells

Rapid Serum-Free Culture of Dendritic Cells from Human Peripheral Blood Monocytes and Their Intracellular Signal Transduction

MONOCYTE-DERIVED DENDRITIC CELLS ISOLATION AND PHENOTYPIC CHARACTERIZATION

Induction of human peripheral blood monocyte-derived dendritic cells in vitro

The Biological Characteristics of Dendritic Cells Derived in Vitro from Myelogeneous Leukemia Cells and Healthy Donor Cells.

Optimal in Vitro Culture Conditions for Murine Predominant Immature Cd8a(+) Dendritic Cells

Serum-free Culture of Dendritic Cells from Patients with Chronic Myeloid Leukemia in Vitro and Estimation of Their Cytotoxicity

Isolation, culture, induction and identification of different subsets of human dendritic cells

Generation of mature dendritic cells from peripheral blood monocytes not purified from the PBMCs by calcium ionophore A23187 and GM-CSF in vitro

A Novel Approach to Induce Human DCs from Monocytes by Triggering 4-1BBL Reverse Signaling

Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy

Induction and Culturing of Dendritic Cells Derived from Human Peripheral Blood Monocytes in Vitro

In vitro generation of mature dendritic cells from peripheral blood mononuclear cell by cocktail of cytokines

In-Depth Analysis of the Impact of Different Serum-Free Media on the Production of Clinical Grade Dendritic Cells for Cancer Immunotherapy